ArticleFrontiers in pharmacology2026
Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg-positive chronic hepatitis B patients during Peg-IFN-α therapy.
Hao Pang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.